Literature DB >> 9553658

Malignant pleural mesothelioma.

P Baas1, H Schouwink, F A Zoetmulder.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9553658     DOI： 10.1023/a:1008239116237

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.

Authors:  Aki Murakami; Yoshihiro Fujimori; Yoshie Yoshikawa; Shusai Yamada; Kunihiro Tamura; Noriko Hirayama; Takayuki Terada; Kozo Kuribayashi; Chiharu Tabata; Kazuya Fukuoka; Tomoko Tamaoki; Takashi Nakano
Journal:  Lung       Date:  2012-01-21       Impact factor: 2.584

Review 2.  Lung cancer * 8: Management of malignant mesothelioma.

Authors:  C Parker; E Neville
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

3.  Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma. A treatment option in selected cases?

Authors:  K Takahashi; J Yoshida; M Nishimura; K Nagai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-02

4.  Effects of hyaluronic acid and CD44 interaction on the proliferation and invasiveness of malignant pleural mesothelioma.

Authors:  Takeshi Hanagiri; Shinji Shinohara; Masaru Takenaka; Yoshiki Shigematsu; Manabu Yasuda; Hidehiko Shimokawa; Yoshika Nagata; Makoto Nakagawa; Hidetaka Uramoto; Tomoko So; Fumihiro Tanaka
Journal:  Tumour Biol       Date:  2012-08-11

5.  French cohort of the uranium processing workers: mortality pattern after 30-year follow-up.

Authors:  Irina Guseva Canu; Elisabeth Cardis; Camille Metz-Flamant; Sylvaine Caër-Lorho; Bernard Auriol; Pascal Wild; Dominique Laurier; Margot Tirmarche
Journal:  Int Arch Occup Environ Health       Date:  2009-08-23       Impact factor: 3.015

6.  Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40.

Authors:  Katharina Leithner; Andreas Leithner; Heimo Clar; Andreas Weinhaeusel; Roman Radl; Peter Krippl; Peter Rehak; Reinhard Windhager; Oskar A Haas; Horst Olschewski
Journal:  Orphanet J Rare Dis       Date:  2006-11-07       Impact factor: 4.123

7.  Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.

Authors:  J M W van Haarst; P Baas; Ch Manegold; J H Schouwink; J A Burgers; H G de Bruin; W J Mooi; R J van Klaveren; M J A de Jonge; J P van Meerbeeck
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

Review 8.  Perspectives on refractory ceramic fiber (RCF) carcinogenicity: comparisons with other fibers.

Authors:  Helmut Greim; Mark J Utell; L Daniel Maxim; Ron Niebo
Journal:  Inhal Toxicol       Date:  2014-09-29       Impact factor: 2.724

Review 9.  Malignant pleural mesothelioma.

Authors:  H L Kindler
Journal:  Curr Treat Options Oncol       Date:  2000-10

Review 10.  Photodynamic therapy for mesothelioma.

Authors:  S M Hahn; R P Smith; J Friedberg
Journal:  Curr Treat Options Oncol       Date:  2001-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.